AEON Earnings AEON Biopharma, Inc.
Reported diluted EPS by fiscal period (SEC EDGAR). Chart & overview →
1–16 of 16
| Q1 2026 | 2026-03-31 | -0.29 | 2026-05-14 | 10-Q |
| FY 2025 | 2025-12-31 | -3.95 | 2026-03-30 | 10-K |
| Q3 2025 | 2025-09-30 | -0.23 | 2025-11-14 | 10-Q |
| Q2 2025 | 2025-06-30 | 0.31 | 2025-08-12 | 10-Q |
| Q1 2026 | 2025-03-31 | 2.28 | 2026-05-14 | 10-Q |
| FY 2025 | 2024-12-31 | 72.93 | 2026-03-30 | 10-K |
| Q3 2025 | 2024-09-30 | 69.53 | 2025-11-14 | 10-Q |
| Q2 2025 | 2024-06-30 | 87.15 | 2025-08-12 | 10-Q |
| Q1 2025 | 2024-03-31 | -227.87 | 2025-05-14 | 10-Q |
| FY 2024 | 2023-12-31 | -627.33 | 2025-03-24 | 10-K |
| Q3 2024 | 2023-09-30 | -8.01 | 2024-11-13 | 10-Q |
| FY 2024 | 2023-07-21 | -0.44 | 2025-03-24 | 10-K |
| Q2 2024 | 2023-06-30 | -0.24 | 2024-08-12 | 10-Q |
| Q1 2024 | 2023-03-31 | -0.13 | 2024-05-14 | 10-Q |
| FY 2023 | 2022-12-31 | -0.38 | 2024-03-29 | 10-K |
| Q3 2023 | 2022-09-30 | -0.13 | 2023-11-13 | 10-Q |
Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Informational only — not financial advice.